Efficacy of Tobacco Quitline for Cancer Survivors

NCT00827866 | Completed

• 2 other identifiers: XPD07-140 Quit-LineR01CA127964
• Study Type: interventional
• Target: 946
• Locations: 1 country
• Sites: 1

Brief Summary

The proposed study is a two-armed randomized controlled clinical trial examining the long-term (one-year) efficacy of telephone intervention conditions for smoking cessation in a high risk medical population; namely, cancer survivors: Proactive telephone recruitment through the Childhood Cancer Survivors Survey (CCSS) St. Jude Life Study, After Completion of Therapy (ACT) Clinic and face to face recruitment at the local West Clinics will serve as the primary methods of recruitment. The specific aims of the study : (1) To recruit nationally a cohort of approximately 1242 smokers who are cancer survivors(621 childhood cancer survivors and 621 adult cancer survivors); 2) To determine the long-term (one year) efficacy of the intervention condition for participants randomly assigned to the Counselor-initiated versus a Self-paced QL; and (3) to find out whether treatment outcomes vary as a function of survivors' age of cancer diagnosis (survivors who diagnosed while adults vs. childhood cancer survivors who diagnosed before the age of 21).

Conditions

Smoking Cessation

Keywords

Tobacco quitline; Childhood cancer survivors; Adult-onset cancer survivors

Outcome Measures

Primary Outcomes (1)

• Self-reported prolonged abstinence and cotinine-validated point-prevalence abstinence at 1 year follow-up

  1 year

Secondary Outcomes (1)

• Account for dose of treatment (NRT use plus number of QL contact) vs. success(quit for one year response) independent of treatment assignment

  1 year

Study Arms (2)

1

OTHER

Counselor-Initiated Tobacco Quit Line Group QL where the counselor contacts the client with a standardized intervention protocol)

Other: Counselor-Initiated Tobacco Quit Line

2

OTHER

Self-Paced Tobacco Quit Line Group which leaves the calling up to participants

Other: Self-Paced Tobacco Quit Line

Interventions

Counselor-Initiated Tobacco Quit Line OTHER

The proposed active intervention will be a the Counselor-Initiated QL which includes provision of 8 weeks of nicotine replacement therapy (NRT) and six scheduled telephone sessions of a behavioral intervention.

Also known as: Other: Arm 1

1

Self-Paced Tobacco Quit Line OTHER

The comparison condition will be the Self-Paced QL with provision of 2 weeks of NRT and encouraged obtainment of additional NRT. If participants in the Self-Paced condition make all six calls, they will receive the same behavioral intervention as in the Counselor-Initiated condition.

Also known as: Arm 2

2

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Participants smokes cigarettes
• Participants is a cancer survivor
• Participant must be at least 18 years of age.
• Childhood cancer survivors must be at least one year out active cancer treatment.
• Participant understands consent procedures.
• Participant speaks English.
• Participant must have access to a telephone for participation

You may not qualify if:

• Inability to understand consent procedures
• Participants with a known contraindication or sensitivity to nicotine replacement therapy may participate in this study; however they will not receive nicotine replacement therapy (NRT) as part of their smoking cessation program.
• Since our participants are childhood cancer survivors and they can be medically fragile and we are interested in providing all eligible participants with NRT to enhance their ability to quit smoking, we added a cautionary conditions list to the recruitment screening form. Those with severe arrhythmias, myocardial infarction, unstable angina, cerebrovascular incident, blood vessel disease, phaeochromocytoma, diabetes, hyperthyroidism, abnormal kidney or liver function, or history of gastritis or peptic ulcers, or who smoke less than 5 cigarettes per day will not receive NRT.
• Patients with questionable NRT eligibility will be discussed/reviewed on a case by case basis with the Staff Family Physician

Sponsors & Collaborators

• St. Jude Children's Research Hospital: lead
• National Cancer Institute (NCI): collaborator

Study Sites (1)

St. Jude Children's Research Hospital

Memphis, Tennessee, 38105, United States

Location

Related Publications (1)

• Klesges RC, Krukowski RA, Klosky JL, Liu W, Srivastava DK, Boyett JM, Lanctot JQ, Hudson MM, Folsom C, Lando H, Robison LL. Efficacy of a tobacco quitline among adult cancer survivors. Prev Med. 2015 Apr;73:22-7. doi: 10.1016/j.ypmed.2014.12.019. Epub 2015 Jan 5.

  PMID: 25572620 DERIVED

Related Links

• St. Jude Children's Research Hospital

MeSH Terms

Conditions

Smoking Cessation

Interventions

DMAC2L protein, human

Condition Hierarchy (Ancestors)

Health Behavior; Behavior

Study Officials

• Robert C Klesges, PhD

  St. Jude Children's Research Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: January 21, 2009
• First Posted: January 23, 2009
• Study Start: October 1, 2008
• Primary Completion: November 1, 2013
• Study Completion: November 1, 2013
• Last Updated: November 25, 2014

Record last verified: 2014-11

Locations

US (1)